Measurement of copper-binding sites on low density lipoprotein

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 4, 2001, Pages 594-602

  Roland, Alexander ^a   Patterson, Rebecca A ^a   Leake, David S ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Atherosclerosis; Copper; Flavonoids; Low density lipoproteins; Quercetin

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN B100; BUFFER; CATECHIN; COPPER; EPICATECHIN; FLAVONOID; HISTIDINE; KAEMPFEROL; LOW DENSITY LIPOPROTEIN; LYSINE; MORIN; MYRICETIN; QUERCETIN;

ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSIS; HUMAN; METAL BINDING; OXIDATION; PRIORITY JOURNAL;

EID: 0035045137     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.4.594     Document Type: Article

References (74)

1. The role of oxidized lipoproteins in atherosclerosis
2. Low density lipoprotein oxidation and its pathological significance
3. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte macrophages during atherogenesis
4. Low density lipoprotein cytotoxicity induced by free radical peroxidation of LDL
5. Role of oxidized human plasma low density lipoproteins in atherosclerosis: Effects on smooth muscle cell proliferation
6. Modification of low density lipoproteins by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipid
7. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells
8. The oxidative modification of low density lipoprotein by macrophages
9. Macrophages require both iron and copper to oxidize low density lipoprotein in Hanks balanced salt solution
10. LDL oxidation by activated monocytes: Characterization of the oxidized LDL and requirement for transition metal ions
11. The possible role of copper ions in atherogenesis: The blue Janus
12. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions
13. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material
14. Transition metal ions within human atherosclerotic lesions can catalyze the oxidation of low density lipoprotein in macrophages
15. Intact human ceruloplasmin oxidatively modifies low density lipoprotein
16. Acidic pH enables ceruloplasmin to catalyze the modification of low density lipoprotein
17. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
18. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
19. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
20. Presence of hypochlorite-modified proteins in human atherosclerotic lesions
21. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
22. The effect of histidine modification on copper-dependent lipid peroxidation in human low density lipoprotein
23. Copper ions promote peroxidation of low density lipoprotein lipid by binding to histidine residues of apolipoprotein B100, but they are reduced at other sites on LDL
24. Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells
25. Oxidation of lipoprotein Lp(a): A comparison with low density lipoproteins
26. Role of lipoprotein copper complex in copper catalyzed peroxidation of low density lipoprotein
27. Inhibition of copper-mediated oxidation of LDL by rat serosal mast cells: A novel cellular protective mechanism involving proteolysis of the substrate under oxidative stress
28. The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low density lipoprotein oxidation
29. Inhibition of the oxidative modification of LDL by nitecapone
30. Phenolic content of various beverages determines the extent of inhibition of human serum and low density lipoprotein oxidation in vitro: Identification and mechanism of action of some cinnamic acid derivatives from red wine
31. Tocopherol as a reductant for Cu(II) in human lipoproteins: Triggering role in the initiation of lipoprotein oxidation
32. Kinetic analysis of copper-induced peroxidation of LDL
33. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper-binding to LDL and 2-oxo-histidine formation
34. Flavonoids inhibit the oxidative modification of low density lipoprotein by macrophages
35. α-Tocopherol consumption during low density lipoprotein oxidation
36. Structure-antioxidant activity relationships of flavonoids and phenolic acids
37. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study
38. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study
39. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: The Zutphen study
40. Flavonoid intake and coronary mortality in Finland: A cohort study
41. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits?
42. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: The Caerphilly study
43. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women
44. Stability of flavonoid complexes of copper(II) and flavonoid antioxidant activity
45. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation
46. Mechanisms of antioxidant activities of quercetin and catechin
47. 2+ ions: Implications for their antioxidant properties
48. The effect of inhibition of free-radical generating enzymes on low density lipoprotein oxidation by macrophages
49. Practical approaches to low density lipoprotein oxidation: Whys, wherefores and pitfalls
50. Batch-to-batch variation of Chelex-100 confounds metal-catalyzed oxidation, leaching of inhibitory compounds from a batch of Chelex-100 and their removal by a pre-washing procedure
51. A simplified method for the quantitative assay of small amounts of protein in biologic material
52. The copper of ascorbic acid oxidase: Exchange studies with radioactive copper
53. Reduction of copper, but not iron, by human low density lipoprotein (LDL): Implications for metal ion-dependent oxidative modification of LDL
54. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts
55. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent
56. Antioxidants of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
57. Metal binding properties of compounds used in biochemistry
58. Hydrogen ion buffers for biological research
59. Chemical modification of low density lipoprotein enhances the number of binding sites for divalent cations
60. Nonenzymatic cleavage of peptide bonds in apoprotein B-100
61. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase
62. 2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low density lipoprotein: Use of a novel inhibitor
63. Evidence for the roles of radicals in protein oxidation in advanced human atherosclerotic plaque
64. Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids
65. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis
66. The effect of protein fouling in microfiltration and ultrafiltration on permeate flux, protein retention and selectivity: A literature review
67. Analysis of protein fouling during ultrafiltration using a two-layer membrane model
68. Low density lipoprotein is saturable by prooxidant copper
69. Copper can promote oxidation of LDL by markedly different mechanisms
70. Flavonoid-metal interactions in biological systems
71. Chemistry of condensed tannin B-ring
72. Polyphenolic flavanols as scavengers of aqueous-phase radicals and as chain-breaking antioxidants
73. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties
74. Kinetics and mechanism of the metal chelate catalyzed oxidation of pyrocatechols